A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution

Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Heitzmann, Edwige, Javelot, Hervé, Weiner, Luisa, Michel, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080510/
https://www.ncbi.nlm.nih.gov/pubmed/27818825
http://dx.doi.org/10.1155/2016/7031245
_version_ 1782462733346668544
author Heitzmann, Edwige
Javelot, Hervé
Weiner, Luisa
Michel, Bruno
author_facet Heitzmann, Edwige
Javelot, Hervé
Weiner, Luisa
Michel, Bruno
author_sort Heitzmann, Edwige
collection PubMed
description Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk factors, including older age and exposure to antipsychotic over a period longer than six months. This case and its dramatic evolution, associated with other cases recently published, suggest reconsidering the real risk of tardive dyskinesia associated with aripiprazole, particularly in the elderly.
format Online
Article
Text
id pubmed-5080510
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50805102016-11-06 A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution Heitzmann, Edwige Javelot, Hervé Weiner, Luisa Michel, Bruno Case Rep Psychiatry Case Report Aripiprazole is reported to be a good clinical safety profile antipsychotic. However, recent data suggest that the risk of tardive dyskinesia could be higher than initially thought. We report the case of aripiprazole-induced tardive dyskinesia with dramatic evolution in a patient with several risk factors, including older age and exposure to antipsychotic over a period longer than six months. This case and its dramatic evolution, associated with other cases recently published, suggest reconsidering the real risk of tardive dyskinesia associated with aripiprazole, particularly in the elderly. Hindawi Publishing Corporation 2016 2016-10-12 /pmc/articles/PMC5080510/ /pubmed/27818825 http://dx.doi.org/10.1155/2016/7031245 Text en Copyright © 2016 Edwige Heitzmann et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Heitzmann, Edwige
Javelot, Hervé
Weiner, Luisa
Michel, Bruno
A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
title A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
title_full A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
title_fullStr A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
title_full_unstemmed A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
title_short A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
title_sort case of aripiprazole-induced tardive dyskinesia with dramatic evolution
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080510/
https://www.ncbi.nlm.nih.gov/pubmed/27818825
http://dx.doi.org/10.1155/2016/7031245
work_keys_str_mv AT heitzmannedwige acaseofaripiprazoleinducedtardivedyskinesiawithdramaticevolution
AT javelotherve acaseofaripiprazoleinducedtardivedyskinesiawithdramaticevolution
AT weinerluisa acaseofaripiprazoleinducedtardivedyskinesiawithdramaticevolution
AT michelbruno acaseofaripiprazoleinducedtardivedyskinesiawithdramaticevolution
AT heitzmannedwige caseofaripiprazoleinducedtardivedyskinesiawithdramaticevolution
AT javelotherve caseofaripiprazoleinducedtardivedyskinesiawithdramaticevolution
AT weinerluisa caseofaripiprazoleinducedtardivedyskinesiawithdramaticevolution
AT michelbruno caseofaripiprazoleinducedtardivedyskinesiawithdramaticevolution

Ejemplares similares